Abstract
This study assessed the relationship between hematocrit levels and severity of obstructive sleep apnea (OSA) and examined how this relationship was affected by the degree of hypoxia as well as by possible confounding factors. Two-hundred sixty three subjects (189 men and 74 women) underwent nocturnal polysomnography with oximetry and had measurements of hematocrit, hemoglobin, white blood cell count, body mass index (BMI), blood pressure (BP), and 24-h urine norepinephrine (NE). Patients with severe OSA [respiratory disturbance index (RDI) >30] had significantly higher hematocrit values than patients with mild to moderate OSA or nonapneic controls (p<0.01). However, only one patient had a hematocrit in the range of clinical polycythemia. Hematocrit levels were significantly correlated with BMI, BP, urinary NE, RDI, percent of time spent at oxygen saturation <90%, and with mean oxygen saturation. Multiple linear regression analysis revealed that mean oxygen saturation, RDI, and percent of time spent at oxygen saturation <90% were significant predictors of hematocrit level, even after controlling for gender, ethnicity, 24-h urine NE, BMI, and BP (p<0.05). The severity of OSA is significantly associated with increased hematocrit, even after controlling for possible confounding variables. However, nocturnal hypoxemia in OSA does not usually lead to clinical polycythemia.
Similar content being viewed by others
References
West JB, Hackett PH, Maret KH, Milledge JS, Peters RM Jr, Pizzo CJ, Winslow RM (1983) Pulmonary gas exchange on the summit of Mount Everest. J Appl Physiol 55:678–687
Miller ME, Garcia JF, Cohen RA, Cronkite EP, Moccia G, Acevedo J (1981) Diurnal levels of immunoreactive erythropoietin in normal subjects and subjects with chronic lung disease. Br J Haematol 49:189–200
Wedzicha JA, Cotes PM, Empey DW (1985) Serum immunoreactive erythropoietin and hypoxic lung disease with and without polycythemia. Clin Sci 69:413–422
Carlson JT, Hedner J, Fagerberg B, Ejnell H, Magnusson B, Fyhrquist F (1992) Secondary polycythemia associated with nocturnal apnea—a relationship not mediated by erythropoietin? J Int Med 231:381–387
Moore-Gillon JC, Treacher DF, Gaminara EJ, Pearson TC, Cameron IR (1986) Intermittent hypoxia in patients with unexplained polycythemia. Br Med J 293:588–590
Messinezy M, Aubry S, O’Connell G, Treacher DF, Pearson TC (1991) Oxygen desaturation in apparent and relative polycythemia. Br Med J 302:216–217
Krieger J, Sforza E, Barthelmebs M, Imbs JL, Kurtz D (1990) Overnight decrease in hematocrit after nasal CPAP treatment in OSA patients. Chest 97:729–730
Krieger J, Sforza E, Delanoe C, Petiau C (1992) Decrease in hematocrit with continuous positive airway pressure treatment in obstructive sleep apnea patients. Eur Respir J 5:228–233
Chin K, Ohi M, Noguchi T, Otsuka N, Tsuboi T, Mishima M, Kuno K (1996) Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 153:1972–1976
Saarelainen S, Hasan J, Seppala E (1996) Effect of nasal CPAP treatment on plasma volume, aldosterone and 24-h blood pressure in obstructive sleep apnea. J Sleep Res 5:181–185
Hoffstein V, Herridge M, Mateika S, Redline S, Strohl KP (1994) Hematocrit levels in sleep apnea. Chest 106:787–791
Hanson CA (2002) Peripheral blood and bone marrow: morphology, counts and differentials, and reactive disorders. In: McClatchey KD (ed) Clinical Laboratory Medicine, 2nd edn. Williams & Wilkins, Philadelphia, pp 797–829
Jacob G, Ertl AC, Shannon JR, Furlan R, Robertson RM, Robertson D (1998) Effect of standing on neurohumoral responses and plasma volume in healthy subjects. J Appl Physiol 84:914–921
Rechtschaffen A, Kales A (1968) A manual of standardized terminology: techniques and scoring system for sleep stages of human subjects. UCLA Brain Information Service/Brain Research Institute, Los Angeles, CA
Kennedy B, Ziegler MG (1990) A more sensitive and specific radioenzymatic assay for catecholamines. Life Sci 47:2143–2153
American Academy of Sleep Medicine (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:667–689
McKeon JL, Saunders NA, Murree-Allen K, Olson LG, Gyalay S, Dickeson J, Houghton A, Wlodarczyk J, Hensley MJ (1990) Urinary uric acid: creatinine ratio, serum erythropoietin, and blood 2,3-diphosphoglycerate in patients with obstructive sleep apnea. Am Rev Respir Dis 142:8–13
Cahan C, Decker MJ, Arnold JL, Washington LH, Veldhuis JD, Goldwasser E, Strohl KP (1992) Diurnal variations in serum erythropoietin levels in healthy subjects and sleep apnea patients. J Appl Physiol 72:2112–2117
Imagawa S, Yamaguchi Y, Higuchi M, Neichi T, Hasegawa Y, Mukai HY, Suzuki N, Yamamoto M, Nagasawa T (2001) Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea–hypopnea syndrome. Blood 98:1255–1257
Winnicki M, Shamsuzzaman A, Lanfranchi P, Accurso V, Olson E, Davison D, Somers VK (2004) Erythropoietin and obstructive sleep apnea. Am J Hypertens 17:783–786
Eisensehr I, Noachtar S (2001) Haematological aspects of obstructive sleep apnoea. Sleep Med Rev 5:207–221
Krieger J, Laks L, Wilcox L, Grunstein RR, Costas LJ, McDougal JG, Sullivan CF (1989) Atrial natriuretic factor release during sleep in obstructive sleep apnea before and during nasal CPAP. Clin Sci 77:407–411
Svatikova A, Shamsuzzaman AS, Wolk R, Phillips BG, Olson LJ, Somers VK (2004) Plasma brain natriuretic peptide in obstructive sleep apnea. Am J Cardiol 94:529–532
Cinar Y, Demir G, Pac M, Cinar AB (1999) Effect of hematocrit on blood pressure via hyperviscosity. Am J Hypertens 12(7):739–743
Partinen M, Guilleminault C (1990) Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest 97:27–32
Peker Y, Hedner J, Kraiczi H, Löth S (2000) Respiratory disturbance index. An independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 162:81–86
Steiner S, Jax T, Evers S, Hennersdorf M, Schwalen A, Strauer BE (2005) Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology 104:92–96
Thompson S, Kienast J, Pyke S, Haverkate F, Van de Loo JW (1995) Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 332:635–641
Acknowledgement
This work was funded by NIH grants HL36005, HL04056, HL44915 and RR00827.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Choi, J., Loredo, J.S., Norman, D. et al. Does obstructive sleep apnea increase hematocrit?. Sleep Breath 10, 155–160 (2006). https://doi.org/10.1007/s11325-006-0064-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-006-0064-z